Cannabis, cannabinoids, and health

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Cannabis is the most widely used illicit psychoactive drug globally.
• Contrary to past beliefs, cannabis use is linked to significant psychiatric and addictive harms.
• Increased cannabis potency and a higher Δ9-THC to CBD ratio contribute to adverse effects.

Purpose of the Study:

• To summarize current developments in cannabis use and the proliferation of synthetic cannabinoids (SCs).
• To highlight the dangers associated with SCs, which are increasingly used by frequent cannabis consumers.
• To acknowledge the therapeutic potential of specific cannabinoids and their derivatives.

Main Methods:

• Review of current scientific literature on cannabis and synthetic cannabinoid trends.
• Analysis of factors contributing to increased complications from cannabis use.
• Examination of the evolving composition and effects of cannabis and SCs.

Main Results:

• Cannabis use is associated with harmful psychiatric and addictive effects.
• Synthetic cannabinoids present significant dangers due to their composition and pharmacological properties.
• While SC use is rising, certain cannabinoids show therapeutic promise for specific conditions.

Conclusions:

• Further research is essential to fully understand the benefit-risk profile of medical cannabis.
• The increasing potency and changing composition of cannabis, alongside the rise of SCs, necessitate careful monitoring and research.
• Distinguishing between recreational and therapeutic cannabis use is crucial.